Pneumococcal Vaccine Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029
The global pneumococcal vaccine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market includes the increasing efforts to curb pneumonia among children in developed countries. Whereas, in the developing countries, the increasing spending on infrastructure and rising awareness towards vaccines, are the factors, which are expected to fuel the market growth during the forecasted period.
According to the report by Jon
Hopkins, in 2019, 5 million children died before reaching the age of 5 years,
out of which around 25% of children died due to pneumonia or diarrhoea. The
developing countries in Asia and Africa contribute to around 70% of the global
death burden of children due to pneumonia. GAVI (the vaccine alliance) is
working towards vaccinating these children who are living in emerging
economies. For many countries including the UK, Canada, Russia, Norway,
Bill Gates and Melinda Gates Foundation had contributed around $1.5 billion
towards the program. By the end of 2018, more than 183 million children
were given shot of the vaccine against pneumococcal.
Some of the key global market
players include Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of
India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL
Ltd., and Astellas Pharma Inc. In June 2020, the Serum Institute of India
started supplying vaccines for $2 as compared to $3.5 per dose earlier. The
company had agreed to provide 10 million doses per year to the countries which
are supported by GAVI for the next 10 years.
To Request
a Sample of our Report on Pneumococcal Vaccine Market:https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market
Pneumococcal Vaccine Market-
Segmentation
By Vaccine Type
- Pneumococcal Conjugate Vaccine (PCV13)
- Pneumococcal Polysaccharide Vaccine (PPSV23)
- Others
By Distribution Channel
- Public
- Private
By Type
- Branded
- Generic
By Age Group
- Children
- Adult
A full report of Pneumococcal
Vaccine Market is available at: https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market
Pneumococcal Vaccine Market–
Segment by Region
North
America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Astellas Pharma Inc.
- China National Biotec Group Company Ltd.
- CSL Ltd.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novavax, Inc.
- Pfizer Inc.
- Walvax Biotechnology Co., Ltd.
- SK Bioscience
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- PnuVax Incorporated
Reasons to
buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a
market research and consulting company known for its crisp and concise reports.
The company is equipped with an experienced team of analysts and consultants.
OMR offers quality syndicated research reports, customized research reports,
consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto
Technologies.
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag
Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Comments
Post a Comment